• 1
    Mahida YR, Wu KC, Jewell DP. Characterization of antigen-presenting activity of intestinal mononuclear cells isolated from normal and inflammatory bowel disease colon and ileum. Immunology 1988;65:5439.
  • 2
    MacDonald TT & Spencer J. Gut immunology. Baillieres Clin Gastroenterol 1990;4:291313.
  • 3
    Spiteri MA, Clarke SW, Poulter LW. Isolation of phenotypically and functionally distinct macrophage subpopulations from human bronchoalveolar lavage. Eur Respir J 1992;5:71726.
  • 4
    Power C, Sreenan S, Hurson B, Burke C, Poulter LW. Distribution of immunocompetent cells in the bronchial wall of clinically healthy subjects showing bronchial hyperresponsiveness. Thorax 1993;48:11259.
  • 5
    Edwards JN & Morris HB. Langerhans' cells and lymphocyte subsets in the female genital tract. Br J Obstet Gynaecol 1985;92:97482.
  • 6
    Kutteh WH & Mestecky J. Secretory immunity in the female reproductive tract. Am J Reprod Immunol 1994;31:406.
  • 7
    White HD, Yeaman GR, Givan AL, Wira CR. Mucosal immunity in the human female reproductive tract: cytotoxic T lymphocyte function in the cervix and vagina of premenopausal and postmenopausal women. Am J Reprod Immunol 1997;37:308.
  • 8
    Kutteh WH, Hatch KD, Blackwell RE, Mestecky J. Secretory immune system of the female reproductive tract: I. Immunoglobulin and secretory component-containing cells. Obstet Gynecol 1988;71:5660.
  • 9
    Rebello R, Green FH, Fox H. A study of the secretory immune system of the female genital tract. Br J Obstet Gynaecol 1975;82:8126.
  • 10
    Gottlieb MS, Schroff R, Schanker HM et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med 1981;305:142531.
  • 11
    Phillips A, Lee CA, Elford J et al. Prediction of progression to AIDS by analysis of CD4 lymphocyte counts in a haemophilic cohort. Aids 1989;3:73741.
  • 12
    Cooper DA, Tindall B, Wilson EJ, Imrie AA, Penny R. Characterization of T lymphocyte responses during primary infection with human immunodeficiency virus. J Infect Dis 1988;157:88996.
  • 13
    Feingold AR, Vermund SH, Burk RD et al. Cervical cytologic abnormalities and papillomavirus in women infected with human immunodeficiency virus. J Acquir Immune Defic Syndr 1990;3:896903.
  • 14
    Hook E, Wd Cannon RO, Nahmias AJ, Lee FF, Campbell Ch Jr, Glasser D et al. Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals [see comments]. J Infect Dis 1992;165:2515.
  • 15
    Imam N, Carpenter CC, Mayer KH, Fisher A, Stein M, Danforth SB. Hierarchical pattern of mucosal candida infections in HIV-seropositive women [see comments]. Am J Med 1990;89:1426.
  • 16
    Anon . Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992; 41(RR−17): 119.
  • 17
    Maiman M, Fruchter RG, Serur E, Levine PA, Arrastia CD, Sedlis A. Recurrent cervical intraepithelial neoplasia in human immunodeficiency virus-seropositive women. Obstet Gynecol 1993;82:1704.
  • 18
    Lim SG, Condez A, Poulter LW. Mucosal macrophage subsets of the gut in HIV decrease in antigen-presenting cell phenotype. Clin Exp Immunol 1993;92:4427.
  • 19
    Janoff EN, Jackson S, Wahl SM, Thomas K, Peterman JH, Smith PD. Intestinal mucosal immunoglobulins during human immunodeficiency virus type 1 infection. J Infect Dis 1994;170:299307.
  • 20
    Agostini C & Semenzato G. Immunologic effects of HIV in the lung. Clin Chest Med 1996;17:63345.
  • 21
    Olaitan A, Johnson MA, MacLean A, Poulter LW. The distribution of immunocompetent cells in the genital tract of HIV-positive women. Aids 1996;10:75964.
  • 22
    Olaitan A, Johnson MA, Reid WM, Poulter LW. Changes to the cytokine microenvironment in the genital tract mucosa of HIV+ women. Clin Exp Immunol 1998;112:1004.DOI: 10.1046/j.1365-2249.1998.00561.x
  • 23
    Ogra PL & Ogra SS. Local antibody response to poliovaccine in the human female genital tract. J Immunol 1973;110:130711.
  • 24
    Lehner T, Bergmeier L, Wang Y, Tao L, Mitchell E. A rational basis for mucosal vaccination against HIV infection. Immunol Rev 1999;170:18396.
  • 25
    Van Damme L, Wright A, Depraetere K et al. A phase I study of a novel potential intraveginal microbicide, PRO 2000, in healthy sexually inactive women. Sexually Transmitted Infections 2000; 76:12630.
  • 26
    Mason D, Abdulaziz Z, Falini B, Stein H. Double immunoenzymatic labelling. In: PolakJM, Van NoordenS, eds. Immunocytochemistry: Practical Applications in Pathology and Biology. Bristol/ Boston: Wright PSG, 1983:11328.
  • 27
    Janossy G, Bofill M, Poulter L. Two colour immunofluorescence analysis of the lymphoid system with monoclonal antibodies. In: PolakJM, Van NoordenS, eds. Immunocytochemistry: Modern Methods and Applications. 2nd edn. Bristol/Boston: Wright PSG, 1986:43855.
  • 28
    Orteu CH, Poulter LW, Rustin MH, Sabin CA, Salmon M, Akbar AN. The role of apoptosis in the resolution of T cell-mediated cutaneous inflammation. J Immunol 1998;161:161929.
  • 29
    Bergquist C, Johansson EL, Lagergard T, Holmgren J, Rudin A. Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina. Infect Immun 1997;65:267684.
  • 30
    Lim SG, Condez A, Lee CA, Johnson MA, Elia C, Poulter LW. Loss of mucosal CD4 lymphocytes is an early feature of HIV infection. Clin Exp Immunol 1993;92:44854.
  • 31
    Lipman MC, Johnson MA, Bray DH, Poulter LH. Changes to alveolar macrophage phenotype in HIV infected individuals with normal CD4 counts and no respiratory disease. Thorax 1995;50:77781.
  • 32
    Bofill M, Lipman M, McLaughlin JE, Johnson MA, Poulter LW. Changes in lung lymphocyte populations reflect those seen in peripheral blood in HIV-1 positive individuals. Eur Respir J 1998;11:54853.
  • 33
    Hirschtick RE, Glassroth J, Jordan MC et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group [see comments]. N Engl J Med 1995;333:84551.
  • 34
    Rankin JA, Collman R, Daniele RP. Acquired immune deficiency syndrome and the lung. Chest 1988;94:15564.
  • 35
    Smith PD, Quinn TC, Strober W, Janoff EN, Masur HNIH. conference. Gastrointestinal infections in AIDS [see comments]. Ann Intern Med 1992;116:6377.
  • 36
    Olaitan A, Mocroft A, McCarthy K, Phillips A, Reid W, Johnson M. Cervical abnormality and sexually transmitted disease screening in human immunodeficiency virus-positive women. Obstet Gynecol 1997;89:715.DOI: 10.1016/s0029-7844(96)00377-8
  • 37
    Jarry A, Cortez A, Rene E, Muzeau F, Brousse N. Infected cells and immune cells in the gastrointestinal tract of AIDS patients. An immunohistochemical study of 127 cases. Histopathology 1990;16:13340.
  • 38
    Franchini M, Walker C, Henrard DR et al. Accumulation of activated CD4+ lymphocytes in the lung of individuals infected with HIV accompanied by increased virus production in patients with secondary infections. Clin Exp Immunol 1995;102:2317.
  • 39
    Lang W, Perkins H, Anderson RE, Royce R, Jewell N, Winkelstein W Jr. Patterns of T lymphocyte changes with human immunodeficiency virus infection: from seroconversion to the development of AIDS. J Acquir Immune Defic Syndr 1989;2:639.
  • 40
    Agostini C, Zambello R, Trentin L et al. Prognostic significance of the evaluation of bronchoalveolar lavage cell populations in patients with HIV-1 infection and pulmonary involvement. Chest 1991;100:16016.
  • 41
    Kotler DP, Gaetz HP, Lange M, Klein EB, Holt PR. Enteropathy associated with the acquired immunodeficiency syndrome. Ann Intern Med 1984;101:4218.
  • 42
    Batman PA, Miller AR, Forster SM, Harris JR, Pinching AJ, Griffin GE. Jejunal enteropathy associated with human immunodeficiency virus infection: quantitative histology. J Clin Pathol 1989;42:27581.
  • 43
    Agostini C, Trentin L, Zambello R, Semenzato G. HIV-1 and the lung. Infectivity, pathogenic mechanisms, and cellular immune responses taking place in the lower respiratory tract. Am Rev Respir Dis 1993;147:103849.
  • 44
    Knight SC, Macatonia SE, Patterson S. HIV I infection of dendritic cells. Int Rev Immunol 1990;6:16375.
  • 45
    Knight SC, Macatonia SE, Cruickshank K, Rudge P, Patterson S. Dendritic cells in HIV-1 and HTLV-1 infection. Adv Exp Med Biol 1993;329:5459.
  • 46
    Teunissen MB, Wormmeester J, Krieg SR et al. Human epidermal Langerhans cells undergo profound morphologic and phenotypical changes during in vitro culture. J Invest Dermatol 1990;94:16673.
  • 47
    Allison MC, Cornwall S, Poulter LW, Dhillon AP, Pounder RE. Macrophage heterogeneity in normal colonic mucosa and in inflammatory bowel disease. Gut 1988;29:15318.
  • 48
    Spiteri MA & Poulter LW. Characterization of immune inducer and suppressor macrophages from the normal human lung. Clin Exp Immunol 1991;83:15762.
  • 49
    Spira AI, Marx PA, Patterson BK et al. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J Exp Med 1996;183:21525.
  • 50
    Marx PA, Spira AI, Gettie A et al. Progesterone implants enhance SIV vaginal transmission and early virus load [see comments]. Nat Med 1996;2:10849.
  • 51
    Haase AT. Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues. Annu Rev Immunol 1999;17:62556.
  • 52
    Knight SC, Macatonia SE, Patterson S. Infection of dendritic cells with HIV1: virus load regulates stimulation and suppression of T-cell activity. Res Virol 1993;144:7580.
  • 53
    Gruters RA, Terpstra FG, De Jong R, Van Noesel CJ, Van Lier RA, Miedema F. Selective loss of T cell functions in different stages of HIV infection. Early loss of anti-CD3-induced T cell proliferation followed by decreased anti-CD3-induced cytotoxic T lymphocyte generation in AIDS- related complex and AIDS. Eur J Immunol 1990;20:103944.
  • 54
    Schnittman SM, Lane HC, Greenhouse J, Justement JS, Baseler M, Fauci AS. Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals. Proc Natl Acad Sci USA 1990;87:605862.
  • 55
    Van Noesel CJ, Gruters RA, Terpstra FG, Schellekens PT, Van Lier RA, Miedema F. Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic human immunodeficiency virus-infected men. J Clin Invest 1990;86:2939.
  • 56
    Laga M, Icenogle JP, Marsella R et al. Genital papillomavirus infection and cervical dysplasia – opportunistic complications of HIV infection. Int J Cancer 1992;50:458.
  • 57
    Sha BE, D'Amico RD, Landay AL et al. Evaluation of immunologic markers in cervicovaginal fluid of HIV- infected and uninfected women: implications for the immunologic response to HIV in the female genital tract. J Acquir Immune Defic Syndr Hum Retrovirol 1997;16:1618.
  • 58
    Belec L, Dupre T, Prazuck T et al. Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) contrasts with normal or impaired IgA local response in HIV infection. J Infect Dis 1995;172:6917.
  • 59
    Moja P, Jalil A, Quesnel A et al. Humoral immune response within the lung in HIV-1 infection. Clin Exp Immunol 1997;110:3418.
  • 60
    Schneider T, Zippel T, Schmidt W et al. Abnormal predominance of IgG in HIV-specific antibodies produced by short-term cultured duodenal biopsy specimens from HIV-infected patients. J Acquir Immune Defic Syndr Hum Retrovirol 1997;16:3339.
  • 61
    Belec L, Gherardi R, Payan C et al. Proinflammatory cytokine expression in cervicovaginal secretions of normal and HIV-infected women. Cytokine 1995;7:56874.DOI: 10.1006/cyto.1995.0077